GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ferric Derisomaltose [MonoFer®]

Company
Sichuan Huiyu Pharmaceutical Co., Ltd
Mechanism
Mechanism not yet reported
Route
Injectable
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ferric Derisomaltose [MonoFer®] and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04913649

    Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients

    Not yet reported dr. P. Noordzij 310 participants Est. completion 2026-12 2 sites
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Recruiting NCT NCT07790562

    A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions

    Not yet reported Sichuan Huiyu Pharmaceutical Co., Ltd 88 participants Est. completion 2026-11-01 1 site
    Other conditions: Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02940860

    Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease

    Not yet reported Pharmacosmos A/S 1538 participants Est. completion 2018-05-29 141 sites
    Chronic kidney disease Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02940886

    Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

    Not yet reported Pharmacosmos A/S 1512 participants Est. completion 2018-03-28 114 sites
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT02962648

    An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)

    Not yet reported Pharmacosmos A/S 103 participants Est. completion 2018-06-12 22 sites
    Other conditions: Iron Deficiency Anemia, Iron Deficiency Anaemia
    View official trial listing →
  • Completed NCT NCT03237065

    Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

    Not yet reported Pharmacosmos A/S 122 participants Est. completion 2018-05-29 15 sites
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT03238911

    Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

    Not yet reported Pharmacosmos A/S 123 participants Est. completion 2018-06-19 16 sites
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ferric Derisomaltose [MonoFer®], Ferric Derisomaltose Injection [MonoFer®]

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.